$10 million from Google Quantum AI and Google.org will fund REPLIQA, a new research program backing Harvard, MIT, UC San Diego, UC Santa Barbara and the University of Arizona.
The initiative targets molecular biology problems that classical computers struggle to model, using quantum computing and AI to simulate protein folding, drug-metabolism chemistry and subatomic cellular processes.
A key early focus is the P450 enzyme, whose role in drug metabolism has long challenged high-performance computing, alongside studies of quantum spin in cells and atomic-scale quantum sensors.
Google says the long-term effort will build quantum-enhanced AI tools and sensing hardware aimed at moving life-sciences research toward practical drug-development and diagnostic uses by the early 2030s.
Is Google's $10M quantum leap into biology a true breakthrough or a bet on technology not yet ready?
As quantum AI decodes life's deepest secrets, who will control the resulting medical breakthroughs?
How will new quantum sensors provide a real-time window into the atomic machinery of living cells?
Google REPLIQA Launch: $10M Investment in Quantum Computing and AI for Breakthroughs in Biology
Overview
Google launched the REPLIQA program on May 15, 2026, marking a strategic move to integrate quantum computing, artificial intelligence, and biological science. This initiative aims to unlock new discoveries in the biological sciences and ultimately enhance human outcomes. Rather than focusing on immediate breakthroughs, REPLIQA is committed to building foundational tools and robust research infrastructure. By fostering a broader scientific ecosystem dedicated to quantum biology research, Google demonstrates a long-term commitment to exploring the intersections of these advanced fields and supporting future advancements in medicine and biology.